Virtu Financial’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Virtu Financial’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-66,717	Closed	-$36K	–	2235
2024 Q4	$36K	Buy	+66,717	New	+$46.5K	﹤0.01%	1205
2022 Q2	–	Sell	-23,650	Closed	-$221K	–	2214
2022 Q1	$221K	Buy	+23,650	New	+$235K	0.02%	733
2019 Q4	$25K	Buy	+2,926	New	+$16.4K	﹤0.01%	1299
2018 Q4	–	Sell	-8,399	Closed	-$336K	–	2074
2018 Q3	$336K	Buy	+8,399	New	+$239K	0.02%	796
2017 Q4	–	Sell	-2,824	Closed	-$66K	–	3153
2017 Q3	$66K	Buy	+2,824	New	+$31.7K	﹤0.01%	2171

Virtu Financial's MRNS Position: Q1 2025 in Review

Virtu Financial sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 66,717 shares — an estimated $36K sold.

Virtu Financial first reported a position in MRNS in Q3 2017 and held it in 5 quarters. The position peaked at $336K in Q3 2018. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

Virtu Financial reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
Virtu Financial sold 66,717 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $36K.
Virtu Financial first reported a position in Marinus Pharmaceuticals, Inc in Q3 2017 and held it in 5 quarters.
Virtu Financial's Marinus Pharmaceuticals, Inc position peaked at $336K in Q3 2018.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.